Poseida Therapeutics Financials

Poseida Therapeutics Stock Summary

Poseida Therapeutics competes with Molecular Partners, Mineralys Therapeutics,, AN2 Therapeutics, Pharvaris, and PepGen. Poseida Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for patients with high unmet medical needs. The company was incorporated in 2014 and is headquartered in San Diego, California. Poseida Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 290 people.

Poseida Therapeutics Key Financial Ratios

Poseida Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Poseida Therapeutics's current stock value. Our valuation model uses many indicators to compare Poseida Therapeutics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Poseida Therapeutics competition to find correlations between indicators driving Poseida Therapeutics's intrinsic value. More Info.Poseida Therapeutics is rated below average in return on equity category among its peers. It is considered to be number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Poseida Therapeutics' earnings, one of the primary drivers of an investment's value.

Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.

If you are still planning to invest in Poseida Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Poseida Therapeutics' history and understand the potential risks before investing.